Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia

被引:0
|
作者
Bredie, SJH
Kiemeney, LA
deHaan, AFJ
Demacker, PNM
Stalenhoef, AFH
机构
[1] UNIV NIJMEGEN,DEPT MED,NIJMEGEN,NETHERLANDS
[2] UNIV NIJMEGEN,DEPT EPIDEMIOL,NIJMEGEN,NETHERLANDS
[3] UNIV NIJMEGEN,DEPT MED STAT,NIJMEGEN,NETHERLANDS
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Familial combined hyperlipidemia (FCH) is a heritable lipid disorder, in which dense low-density lipoprotein (LDL) subfraction profiles due to a predominance of small dense LDL particles are frequently observed. These small dense LDL particles are associated with cardiovascular disease. Using segregation analysis, we investigated to what extent these LDL subfraction profiles are genetically determined; also, the mode of inheritance was studied. Individual LDL subfraction profiles were determined by density gradient ultracentrifugation in 623 individuals of 40 well-defined Dutch FCH families. The individual LDL subfraction profile was defined as a quantitative trait by the continuous variable K, a reliable estimate of the relative contribution of each LDL subfraction to the overall profile. Variation in parameter K due to age, sex, and hormonal status was taken into account by introducing liability classes. Segregation analysis was performed by fitting a series of class D regressive models, implemented in the Statistical Analysis for Genetic Epidemiology (SAGE) program, after which genetic models were compared using log-likelihood ratio tests. Our data show that 60% of the variability of parameter K could be explained by lipid and lipoprotein levels and that a major autosomal locus, recessively inherited, with a population frequency of .42 +/- .07, and an additional polygenic component of .25 best explained the clustering of atherogenic dense LDL subfraction profiles in these FCH families. Therefore, dense LDL subfraction profiles, associated with elevated lipid levels, appear to have a genetic basis in FCH.
引用
收藏
页码:812 / 822
页数:11
相关论文
共 50 条
  • [21] BOTH INHERITED SUSCEPTIBILITY AND ENVIRONMENTAL EXPOSURE DETERMINE THE LOW-DENSITY-LIPOPROTEIN SUBFRACTION PATTERN DISTRIBUTION IN HEALTHY DUTCH FAMILIES
    DEGRAAF, J
    SWINKELS, DW
    DEHAAN, AFJ
    DEMACKER, PNM
    STALENHOEF, AFH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1992, 51 (06) : 1295 - 1310
  • [22] Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
    Calabresi, L
    Donati, D
    Pazzucconi, F
    Sirtori, CR
    Franceschini, G
    ATHEROSCLEROSIS, 2000, 148 (02) : 387 - 396
  • [23] INHERITANCE OF LOW-DENSITY-LIPOPROTEIN SUBCLASS PATTERNS IN FAMILIAL COMBINED HYPERLIPIDEMIA
    AUSTIN, MA
    BRUNZELL, JD
    FITCH, WL
    KRAUSS, RM
    ARTERIOSCLEROSIS, 1990, 10 (04): : 520 - 530
  • [24] COMPARISON OF GEMFIBROZIL VERSUS SIMVASTATIN IN FAMILIAL COMBINED HYPERLIPIDEMIA AND EFFECTS ON APOLIPOPROTEIN-B-CONTAINING LIPOPROTEINS, LOW-DENSITY-LIPOPROTEIN SUBFRACTION PROFILE, AND LOW-DENSITY-LIPOPROTEIN OXIDIZABILITY
    BREDIE, SJH
    DEBRUIN, TWA
    DEMACKER, PNM
    KASTELEIN, JJP
    STALENHOEF, AFH
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (05): : 348 - 353
  • [25] Low-density lipoprotein particle size loci in familial combined hyperlipidemia - Evidence for multiple loci from a genome scan
    Badzioch, MD
    Igo, RP
    Gagnon, F
    Brunzell, JD
    Krauss, RM
    Motulsky, AG
    Wijsman, EM
    Jarvik, GP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) : 1942 - 1950
  • [26] Frequency of Low-Density Lipoprotein Receptor Gene Mutations in Patients With a Clinical Diagnosis of Familial Combined Hyperlipidemia in a Clinical Setting
    Civeira, Fernando
    Jarauta, Estibaliz
    Cenarro, Ana
    Garcia-Otin, Angel L.
    Tejedor, Diego
    Zambon, Daniel
    Mallen, Miguel
    Ros, Emilio
    Pocovi, Miguel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (19) : 1546 - 1553
  • [27] ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION OF THE DENSE LOW-DENSITY-LIPOPROTEIN SUBFRACTION IN HEALTHY-SUBJECTS
    DEGRAAF, J
    HAKLEMMERS, HLM
    HECTORS, MPC
    DEMACKER, PNM
    HENDRIKS, JCM
    STALENHOEF, AFH
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02): : 298 - 306
  • [28] Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia
    Yang, CY
    Gu, ZW
    Xie, YH
    Valentinova, NV
    Yang, ML
    Yeshurun, D
    Quion, JAV
    Gotto, AM
    ATHEROSCLEROSIS, 1996, 126 (01) : 105 - 116
  • [29] Low-density lipoprotein apheresis as a treatment option for hyperlipidemia
    Mehta P.K.
    Baer J.
    Nell C.
    Sperling L.S.
    Current Treatment Options in Cardiovascular Medicine, 2009, 11 (4) : 279 - 288
  • [30] Effects of Atorvastatin versus Fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia
    Frost, RJA
    Otto, C
    Geiss, HC
    Schwandt, P
    Parhofer, KG
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (01): : 44 - 48